granegis 1 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - granisetrons - apvalkotā tablete - 1 mg
granegis 2 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - granisetrons - apvalkotā tablete - 2 mg
tramadol kalceks 50 mg/ml šķīdums injekcijām/infūzijām
kalceks, a/s, latvia - tramadola hidrohlorīds - Šķīdums injekcijām/infūzijām - 50 mg/ml
cyclophosphamide accord 500 mg pulveris injekciju/infūziju šķīduma pagatavošanai
accord healthcare b.v., netherlands - ciklofosfamīds - pulveris injekciju/infūziju šķīduma pagatavošanai - 500 mg
cyclophosphamide accord 1000 mg pulveris injekciju/infūziju šķīduma pagatavošanai
accord healthcare b.v., netherlands - ciklofosfamīds - pulveris injekciju/infūziju šķīduma pagatavošanai - 1000 mg
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiski līdzekļi - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.